Free Account Opening + AMC Free Demat
Loading...

CBC Pharma IPO vs Janus IPO

Comparision between CBC Pharma IPO and Janus IPO.

IPO Details

CBC Pharma IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Janus IPO is a SME Fixed Price Issue proposed to list at BSE SME.

  CBC Pharma IPO Janus IPO
Logo CBC Pharma IPO Logo Janus IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME BSE SME
Lead Managers Beeline Broking Ltd First Overseas Capital Limited
Registrar Link Intime India Private Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of CBC Pharma IPO is up to ₹10.20 Cr whereas the issue size of the Janus IPO is up to ₹8.00 Cr. The final issue price of CBC Pharma IPO is ₹51.00 per share and of Janus IPO is ₹50.00 per share.

  CBC Pharma IPO Janus IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹51.00 per share ₹50.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 2000 shares 3000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 20,00,000 shares 15,99,000 shares
Issue Size Total (Amount) up to ₹10.20 Cr up to ₹8.00 Cr

IPO Timetable

CBC Pharma IPO opens on Jan 31, 2020, while Janus IPO opens on Jan 27, 2020. The closing date of CBC Pharma IPO and Janus IPO is Feb 06, 2020, and Jan 30, 2020, respectively.

  CBC Pharma IPO Janus IPO
Anchor Bid Date
Issue Open Jan 31, 2020 Jan 27, 2020
Issue Close Feb 06, 2020 Jan 30, 2020
Basis Of Allotment (Tentative) Feb 11, 2020 Feb 04, 2020
Initiation of Refunds (Tentative) Feb 13, 2020 Feb 05, 2020
Credit of Share (Tentative) Feb 13, 2020 Feb 06, 2020
Listing date (Tentative) Feb 14, 2020 Feb 06, 2020
Anchor Lockin End date 1 Mar 12, 2020 Mar 05, 2020
Anchor Lockin End date 2 May 11, 2020 May 04, 2020

Financials

CBC Pharma IPO P/E ratio is 51, as compared to Janus IPO P/E ratio of 57.

  CBC Pharma IPO Janus IPO
Financial
Summary of financial Information (Restated)
Particulars For the year/period ended (Rs in Lakhs)
30-July-19 31-Mar-19 31-Mar-18 31-Mar-17
Total Assets 8,594.26 8,285.52 5,805.76 5,589.60
Total Revenue 3,344.50 10,671.83 9,773.41 9,028.11
Profit After Tax 24.88 62.59 103.38 66.03
Summary of financial Information (Restated)
Particulars For the year/period ended (Rs in Lakh)
31-Aug-19 31-Mar-19 31-Mar-18 31-Mar-17
Total Assets 960.49 958.37 858.82 687.08
Total Revenue 1,072.71 1,714.04 2,515.60 1281.98
Profit After Tax 29.19 48.04 22.05 42.94
Promoter Shareholding (Pre-Issue) 96.72% 90.23%
Promoter Shareholding (Post-Issue) 71.08% 65.09%
P/E Ratio 51 57
Market Cap ₹38.48 Cr. ₹28.70 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the CBC Pharma IPO retail investors (RII) are offered 9,50,000 shares while in Janus IPO retail investors are offered 9,50,000 shares. Qualified institutional buyers (QIB) are offered in CBC Pharma IPO and in Janus IPO.

  CBC Pharma IPO Janus IPO
Anchor Investor Reserveration
Market Maker Reserveration 2,00,000 shares 81,000 shares
QIB
NII 9,50,000 shares 7,59,000 shares
RII 9,50,000 shares 7,59,000 shares
Employee
Others
Total 19,00,000 shares 15,18,000 shares

Bids Received (Subscription)

CBC Pharma IPO subscribed 1.65x in total, whereas Janus IPO subscribed 1.26x.

  CBC Pharma IPO Janus IPO
QIB (times)
NII (times) 1.87x 1.03x
Big NII (times)
Small NII (times)
RII (times) 1.44x 1.48x
Employee (times)
Other (times)
Total (times) 1.65x 1.26x

Comments

Add a public comment...